Discounted Cash Flow Rating

Return on Equity Rating

Debt to Equity Rating

Price to Earnings Rating

Analyst Rating

Simple Moving Average

Exponential Moving Average

Relative Strength Index

Standard Deviation

Williams %R

Average Directional Index

Insider Trading

Neutral

Wall Street Data Solutions Rating

()

No description provided.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/01/1970

Market Cap

N/A

Shares Outstanding

N/A

Weighted SO

N/A

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

Beta

N/A

Last Div

N/A

Range

N/A

Chg

N/A

Avg Vol

N/A

Mkt Cap

N/A

Exch

N/A

Country

N/A

Phone

N/A

DCF Diff

N/A

DCF

N/A

Div Yield

N/A

P/S

N/A

EV Multiple

N/A

P/FV

N/A

Div Yield %

N/A

P/E

N/A

PEG

N/A

Payout

N/A

Current Ratio

N/A

Quick Ratio

N/A

Cash Ratio

N/A

DSO

N/A

DIO

N/A

Op Cycle

N/A

DPO

N/A

CCC

N/A

Gross Margin

N/A

Op Margin

N/A

Pretax Margin

N/A

Net Margin

N/A

Eff Tax Rate

N/A

ROA

N/A

ROE

N/A

ROCE

N/A

NI/EBT

N/A

EBT/EBIT

N/A

EBIT/Rev

N/A

Debt Ratio

N/A

D/E

N/A

LT Debt/Cap

N/A

Total Debt/Cap

N/A

Int Coverage

N/A

CF/Debt

N/A

Equity Multi

N/A

Rec Turnover

N/A

Pay Turnover

N/A

Inv Turnover

N/A

FA Turnover

N/A

Asset Turnover

N/A

OCF/Share

N/A

FCF/Share

N/A

Cash/Share

N/A

OCF/Sales

N/A

FCF/OCF

N/A

CF Coverage

N/A

ST Coverage

N/A

CapEx Coverage

N/A

Div&CapEx Cov

N/A

P/BV

N/A

P/B

N/A

P/S

N/A

P/E

N/A

P/FCF

N/A

P/OCF

N/A

P/CF

N/A

PEG

N/A

P/S

N/A

EV Multiple

N/A

P/FV

N/A

DPS

N/A

Latest Headlines (EST)

GlobeNewswire Inc. May 30, 05:00 Roche’s fenebrutinib maintains near-complete suppression of disease activity and disability progression for up to two years in people with relapsing multiple sclerosis GlobeNewswire Inc. May 23, 05:10 Roche announces new collaboration with Broad Clinical Labs to accelerate adoption of cutting-edge SBX sequencing technology GlobeNewswire Inc. May 23, 05:00 New two-year follow-up of Roche’s Columvi extends overall survival in relapsed or refractory diffuse large B-cell lymphoma patients GlobeNewswire Inc. Apr 25, 05:00 New England Journal of Medicine publishes phase III data showing single-dose Xofluza significantly reduces influenza virus transmission GlobeNewswire Inc. Apr 14, 05:00 European Commission approves Roche’s Columvi as the first bispecific antibody for diffuse large B-cell lymphoma after initial therapy GlobeNewswire Inc. Mar 11, 23:30 Breast Cancer Diagnostics Market Set for 6.9% CAGR Growth, projected to Hit USD 12.45 Billion by 2035 The Motley Fool Mar 08, 15:02 Is This Beaten-Down Artificial Intelligence (AI) Stock a Buy? GlobeNewswire Inc. Feb 26, 01:30 Liquid Biopsy Market Worth US$11.3 billion at a robust CAGR of 11.9% | MarketsandMarkets™. GlobeNewswire Inc. Feb 18, 23:30 Pancreatic Cancer Diagnostic Market to Reach $3.2 billion, Globally, by 2035 at 5.9% CAGR: Allied Market Research GlobeNewswire Inc. Nov 22, 00:30 Global Life Science and Chemical Instruments Market Set to Reach USD 79.7 Billion by 2034, Projected to Grow at 5.3% CAGR | Future Market Insights, Inc. GlobeNewswire Inc. Oct 28, 00:30 Global Lung Cancer Therapeutics Market Set to Reach USD 48,725.9 Million by 2026 with an Impressive CAGR of 13.4% growth over the forecast period 2022 to 2032 | FMI GlobeNewswire Inc. Oct 23, 05:00 [Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong sales growth of 9% (CER) continues in the third quarter of 2024; Group sales increase 6% in the first nine months GlobeNewswire Inc. Oct 16, 04:00 Hyaluronic Acid Market Driven by Increasing Demand for Cosmetics and Expected to Grow over 21 Bn by 2032 Benzinga Oct 07, 02:46 Economist Justin Wolfers Points To Obesity Rate Decline As Ozempic And Wegovy Spur Historic Shift In Fight Against Obesity — Has US Reached A Turning Point? GlobeNewswire Inc. Sep 22, 04:30 Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight GlobeNewswire Inc. Sep 13, 00:30 Liquid Biopsy Market to Reach $ 32.54 Billion, Globally, by 2033 at 11.61% CAGR: The Brainy Insights GlobeNewswire Inc. Sep 13, 00:00 OTC ?? ??, OTC ???? ?? ??? ??? ?? ??? ?? GlobeNewswire Inc. Sep 13, 00:00 OTC Markets Group ?????? OTC Overnight????????? GlobeNewswire Inc. Sep 13, 00:00 OTC?????????? (OTC Markets Group)?OTC??????? (OTC Overnight) ????????????????????????? GlobeNewswire Inc. Sep 13, 00:00 OTC Markets Group ?????? OTC Overnight?????????

Revenue Product Segmentation